PNPLA3 and hepatocellular carcinoma: Different genetic loci were discovered and validated in large patient cohorts, with some increasing the risk for HCC, such as the presence of the PNPLA3 minor variant 148M [1,7,8], and with others reducing the risk, such as the HSD17B13 rs72613567:TA variant [9,10].